{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T05:18:08Z","timestamp":1791955088389,"version":"4.3.4"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T00:00:00Z","timestamp":1638144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T00:00:00Z","timestamp":1638144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012401","name":"beijing science and technology planning project","doi-asserted-by":"publisher","award":["Z161100000216134"],"award-info":[{"award-number":["Z161100000216134"]}],"id":[{"id":"10.13039\/501100012401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"national natural science foundation of china","doi-asserted-by":"publisher","award":["81430044"],"award-info":[{"award-number":["81430044"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Alzheimer\u2019s disease (AD) is a progressive, degenerative, and terminal disease without cure. There is an urgent need for a new strategy to treat AD. The aim of this study was to investigate the effects of intermittent hypoxic treatment (IHT) on cognitive functions in a mouse model of AD and unravel the mechanism of action of IHT.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Six-month-old APPswe\/PS1dE9 (APP\/PS1) male mice were exposed to hypoxic environment (14.3% O<jats:sub>2<\/jats:sub>) 4 h\/day for 14 days or 28 days. Cognitive functions were measured by Morris water maze test after either 14 days or 42 days of interval. Thereafter the distribution of amyloid plaque and microglial activation were determined by mouse brain immunohistochemistry, while the amyloid beta (A\u03b2) and inflammatory cytokines were measured by ELISA and Western Blot. Microarray was used for studying gene expressions in the hippocampus.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>IHT for 14 days or 28 days significantly improved the spatial memory ability of the 6-month-old APP\/PS1 mice. The memory improvement by 14 days IHT lasted to 14 days, but not to 42 days. The level of A\u03b2 plaques and neurofilament accumulations was reduced markedly after the IHT exposure. IHT reduced the pro-inflammatory cytokines IL-1\u03b2, IL-6 levels, and \u03b2-secretase cleavage of APP processing which implies reduced A\u03b2 production. Microarray analysis revealed a large number of genes in the hippocampus were significantly altered which are known to be metabolism-regulated genes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study provides evidence of the beneficial effect of IHT on the progression of AD by alleviating memory impairment, reducing A\u03b2 accumulation and inflammation in the brain. IHT can be developed as a novel measure to relieve the progression of AD by targeting multiple pathways in the AD pathogenesis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13195-021-00935-z","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T23:02:36Z","timestamp":1638226956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Intermittent hypoxia treatment alleviates memory impairment in the 6-month-old APPswe\/PS1dE9 mice and reduces amyloid beta accumulation and inflammation in the brain"],"prefix":"10.1186","volume":"13","author":[{"given":"Xiangpei","family":"Yue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingnan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4929-7103","authenticated-orcid":false,"given":"Lingling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,29]]},"reference":[{"issue":"4","key":"935_CR1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1469-445X.2002.tb00058.x","volume":"87","author":"R Germack","year":"2002","unstructured":"Germack R, Leon-Velarde F, Valdes De La Barra R, Farias J, Soto G, Richalet JP. Effect of intermittent hypoxia on cardiovascular function, adrenoceptors and muscarinic receptors in Wistar rats. Exp Physiol. 2002;87(4):453\u201360.","journal-title":"Exp Physiol."},{"issue":"9","key":"935_CR2","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s40279-014-0204-8","volume":"44","author":"BD McLean","year":"2014","unstructured":"McLean BD, Gore CJ, Kemp J. Application of 'live low-train high' for enhancing normoxic exercise performance in team sport athletes. Sports Med. 2014;44(9):1275\u201387.","journal-title":"Sports Med."},{"issue":"10","key":"935_CR3","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1249\/MSS.0000000000000630","volume":"47","author":"F Brocherie","year":"2015","unstructured":"Brocherie F, Millet GP, Hauser A, et al. \"Live High-Train Low and High\" Hypoxic Training Improves Team-Sport Performance. Med Sci Sports Exerc. 2015;47(10):2140\u20139.","journal-title":"Med Sci Sports Exerc."},{"issue":"3","key":"935_CR4","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/cpf.12296","volume":"37","author":"D Susta","year":"2017","unstructured":"Susta D, Dudnik E, Glazachev OS. A programme based on repeated hypoxia-hyperoxia exposure and light exercise enhances performance in athletes with overtraining syndrome: a pilot study. Clin Physiol Funct Imaging. 2017;37(3):276\u201381.","journal-title":"Clin Physiol Funct Imaging."},{"issue":"1","key":"935_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1089\/ham.2007.1053","volume":"9","author":"VB Shatilo","year":"2008","unstructured":"Shatilo VB, Korkushko OV, Ischuk VA, Downey HF, Serebrovskaya TV. Effects of intermittent hypoxia training on exercise performance, hemodynamics, and ventilation in healthy senior men. High Alt Med Biol. 2008;9(1):43\u201352.","journal-title":"High Alt Med Biol."},{"key":"935_CR6","first-page":"41","volume":"2","author":"TN Tsyganova","year":"2004","unstructured":"Tsyganova TN. Comparative efficacy of anemia treatment in mountain health resort and using normobaric intermittent hypoxic training. Vopr Kurortol Fizioter Lech Fiz Kult. 2004;2:41\u20132.","journal-title":"Vopr Kurortol Fizioter Lech Fiz Kult"},{"issue":"5","key":"935_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/BF00841515","volume":"105","author":"EE Ustinova","year":"1988","unstructured":"Ustinova EE, Saltykova VA, Didenko VV, Beloshitski\u012d PV, Meerson FZ. Effects of adaptation to periodic and continuous hypoxia in disorders of electrical stability of the heart in postinfarction cardiosclerosis. Biull Eksp Biol Med. 1988;105(5):533\u20135.","journal-title":"Biull Eksp Biol Med."},{"issue":"3","key":"935_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s11325-009-0289-8","volume":"14","author":"M Burtscher","year":"2010","unstructured":"Burtscher M, Gatterer H, Szubski C, Pierantozzi E, Faulhaber M. Effects of interval hypoxia on exercise tolerance: special focus on patients with CAD or COPD. Sleep Breath. 2010;14(3):209\u201320.","journal-title":"Sleep Breath."},{"issue":"5","key":"935_CR9","first-page":"10","volume":"57","author":"AL Syrkin","year":"2017","unstructured":"Syrkin AL, Glazachev OS, Kopylov FY, Dudnik EN, Zagaynaya EE, Tuter DS. Adaptation to Intermittent Hypoxia-Hyperoxia in the Rehabilitation of Patients With Ischemic Heart Disease: Exercise Tolerance and Quality of Life. Kardiologiia. 2017;57(5):10\u20136.","journal-title":"Kardiologiia."},{"key":"935_CR10","first-page":"104","volume":"6","author":"TV Serebrovskaia","year":"1998","unstructured":"Serebrovskaia TV, Man'kovskaia IN, et al. A method for intermittent hypoxic exposures in the combined treatment of bronchial asthma patients. Lik Sprava. 1998;6:104\u20138.","journal-title":"Lik Sprava"},{"issue":"Suppl 1","key":"935_CR11","first-page":"35","volume":"54","author":"TV Serebrovskaya","year":"2003","unstructured":"Serebrovskaya TV, Swanson RJ, Kolesnikova EE. Intermittent hypoxia: mechanisms of action and some applications to bronchial asthma treatment. J Physiol Pharmacol. 2003;54(Suppl 1):35\u201341.","journal-title":"J Physiol Pharmacol."},{"key":"935_CR12","first-page":"21","volume":"5","author":"B IKh","year":"2007","unstructured":"IKh B. Intermittent hypoxic training in the sanatorium and spa treatment for patients with chronic obstructive pulmonary disease. Vopr Kurortol Fizioter Lech Fiz Kult. 2007;5:21\u20134.","journal-title":"Vopr Kurortol Fizioter Lech Fiz Kult"},{"issue":"8","key":"935_CR13","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1097\/HJH.0b013e32832c0018","volume":"27","author":"T Haider","year":"2009","unstructured":"Haider T, Casucci G, Linser T, et al. Interval hypoxic training improves autonomic cardiovascular and respiratory control in patients with mild chronic obstructive pulmonary disease. J Hypertens. 2009;27(8):1648\u201354.","journal-title":"J Hypertens."},{"issue":"3","key":"935_CR14","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/ACI.0b013e32833903a6","volume":"10","author":"M Vogtel","year":"2010","unstructured":"Vogtel M, Michels A. Role of intermittent hypoxia in the treatment of bronchial asthma and chronic obstructive pulmonary disease. Curr Opin Allergy Clin Immunol. 2010;10(3):206\u201313.","journal-title":"Curr Opin Allergy Clin Immunol."},{"issue":"38","key":"935_CR15","doi-asserted-by":"publisher","first-page":"12653","DOI":"10.1523\/JNEUROSCI.6414-09.2010","volume":"30","author":"XH Zhu","year":"2010","unstructured":"Zhu XH, Yan HC, Zhang J, et al. Intermittent hypoxia promotes hippocampal neurogenesis and produces antidepressant-like effects in adult rats. J Neurosci. 2010;30(38):12653\u201363.","journal-title":"J Neurosci."},{"key":"935_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fnmol.2011.00005","volume":"4","author":"K Zhang","year":"2011","unstructured":"Zhang K, Zhu L, Fan M. Oxygen, a Key Factor Regulating Cell Behavior during Neurogenesis and Cerebral Diseases. Front Mol Neurosci. 2011;4:5.","journal-title":"Front Mol Neurosci."},{"key":"935_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.nbd.2013.12.010","volume":"64","author":"K Zhang","year":"2014","unstructured":"Zhang K, Zhao T, Huang X, et al. Notch1 mediates postnatal neurogenesis in hippocampus enhanced by intermittent hypoxia. Neurobiol Dis. 2014;64:66\u201378.","journal-title":"Neurobiol Dis."},{"issue":"12","key":"935_CR18","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1177\/1535370216649060","volume":"241","author":"EB Manukhina","year":"2016","unstructured":"Manukhina EB, Downey HF, Shi X, Mallet RT. Intermittent hypoxia training protects cerebrovascular function in Alzheimer's disease. Exp Biol Med (Maywood). 2016;241(12):1351\u201363.","journal-title":"Exp Biol Med (Maywood)."},{"key":"935_CR19","doi-asserted-by":"publisher","first-page":"995","DOI":"10.3389\/fphys.2019.00995","volume":"10","author":"JC Chang","year":"2019","unstructured":"Chang JC, Hu WF, Lee WS, et al. Intermittent Hypoxia Induces Autophagy to Protect Cardiomyocytes From Endoplasmic Reticulum Stress and Apoptosis. Front Physiol. 2019;10:995.","journal-title":"Front Physiol."},{"issue":"4","key":"935_CR20","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med. 2010;362(4):329\u201344.","journal-title":"N Engl J Med."},{"key":"935_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/B978-0-12-804766-8.00013-3","volume":"167","author":"JA Soria Lopez","year":"2019","unstructured":"Soria Lopez JA, Gonz\u00e1lez HM, L\u00e9ger GC. Alzheimer's disease. Handb Clin Neurol. 2019;167:231\u201355.","journal-title":"Handb Clin Neurol."},{"issue":"2","key":"935_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jalz.2017.10.009","volume":"14","author":"R Brookmeyer","year":"2018","unstructured":"Brookmeyer R, Abdalla N, Kawas CH, Corrada MM. Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States. Alzheimers Dement. 2018;14(2):121\u20139.","journal-title":"Alzheimers Dement."},{"issue":"13","key":"935_CR23","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","volume":"83","author":"I Grundke-Iqbal","year":"1986","unstructured":"Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A. 1986;83(13):4913\u20137.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"5054","key":"935_CR24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184\u20135.","journal-title":"Science."},{"issue":"6","key":"935_CR25","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2174\/156720511796717177","volume":"8","author":"CA Lasagna-Reeves","year":"2011","unstructured":"Lasagna-Reeves CA, Castillo-Carranza DL, Jackson GR, Kayed R. Tau oligomers as potential targets for immunotherapy for Alzheimer's disease and tauopathies. Curr Alzheimer Res. 2011;8(6):659\u201365.","journal-title":"Curr Alzheimer Res."},{"issue":"3","key":"935_CR26","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3233\/JAD-130653","volume":"37","author":"A Takashima","year":"2013","unstructured":"Takashima A. Tauopathies and tau oligomers. J Alzheimers Dis. 2013;37(3):565\u20138.","journal-title":"J Alzheimers Dis."},{"key":"935_CR27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-pathol-020712-163927","volume":"10","author":"HV Vinters","year":"2015","unstructured":"Vinters HV. Emerging concepts in Alzheimer's disease. Annu Rev Pathol. 2015;10:291\u2013319.","journal-title":"Annu Rev Pathol."},{"issue":"3","key":"935_CR28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.14336\/AD.2017.0112","volume":"8","author":"DL Castillo-Carranza","year":"2017","unstructured":"Castillo-Carranza DL, Nilson AN, Van Skike CE, et al. Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer's Disease and Related Tauopathies. Aging Dis. 2017;8(3):257\u201366.","journal-title":"Aging Dis."},{"issue":"6","key":"935_CR29","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","volume":"148","author":"Y Huang","year":"2012","unstructured":"Huang Y, Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell. 2012;148(6):1204\u201322.","journal-title":"Cell."},{"issue":"5","key":"935_CR30","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0896-6273(00)80230-5","volume":"17","author":"DR Borchelt","year":"1996","unstructured":"Borchelt DR, Thinakaran G, Eckman CB, et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42\/1-40 ratio in vitro and in vivo. Neuron. 1996;17(5):1005\u201313.","journal-title":"Neuron."},{"issue":"5","key":"935_CR31","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/j.1750-3639.2011.00560.x","volume":"22","author":"E Aso","year":"2012","unstructured":"Aso E, Lomoio S, L\u00f3pez-Gonz\u00e1lez I, et al. Amyloid generation and dysfunctional immunoproteasome activation with disease progression in animal model of familial Alzheimer's disease. Brain Pathol. 2012;22(5):636\u201353.","journal-title":"Brain Pathol."},{"key":"935_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.neurobiolaging.2017.10.007","volume":"62","author":"R Shapira","year":"2018","unstructured":"Shapira R, Solomon B, Efrati S, Frenkel D, Ashery U. Hyperbaric oxygen therapy ameliorates pathophysiology of 3xTg-AD mouse model by attenuating neuroinflammation. Neurobiol Aging. 2018;62:105\u201319.","journal-title":"Neurobiol Aging."},{"issue":"22","key":"935_CR33","doi-asserted-by":"publisher","first-page":"14392","DOI":"10.1128\/JVI.79.22.14392-14403.2005","volume":"79","author":"Y Guo","year":"2005","unstructured":"Guo Y, Guo H, Zhang L, et al. Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells. J Virol. 2005;79(22):14392\u2013403.","journal-title":"J Virol."},{"issue":"9","key":"935_CR34","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/nbt1242","volume":"24","author":"TA Patterson","year":"2006","unstructured":"Patterson TA, Lobenhofer EK, Fulmer-Smentek SB, et al. Performance comparison of one-color and two-color platforms within the MicroArray Quality Control (MAQC) project. Nat Biotechnol. 2006;24(9):1140\u201350.","journal-title":"Nat Biotechnol."},{"issue":"4","key":"935_CR35","doi-asserted-by":"publisher","first-page":"423","DOI":"10.4081\/916","volume":"48","author":"S Mazzetti","year":"2004","unstructured":"Mazzetti S, Frigerio S, Gelati M, Salmaggi A, Vitellaro-Zuccarello L. Lycopersicon esculentum lectin: an effective and versatile endothelial marker of normal and tumoral blood vessels in the central nervous system. Eur J Histochem. 2004;48(4):423\u20138.","journal-title":"Eur J Histochem."},{"key":"935_CR36","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/neuro.02.002.2009","volume":"2","author":"O Engmann","year":"2009","unstructured":"Engmann O, Giese KP. Crosstalk between Cdk5 and GSK3beta: Implications for Alzheimer's Disease. Front Mol Neurosci. 2009;2:2.","journal-title":"Front Mol Neurosci."},{"issue":"1","key":"935_CR37","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1021\/acs.jmedchem.0c00931","volume":"64","author":"A De Simone","year":"2021","unstructured":"De Simone A, Tumiatti V, Andrisano V, Milelli A. Glycogen Synthase Kinase 3\u03b2: A New Gold Rush in Anti-Alzheimer's Disease Multitarget Drug Discovery. J Med Chem. 2021;64(1):26\u201341.","journal-title":"J Med Chem."},{"issue":"5","key":"935_CR38","doi-asserted-by":"publisher","first-page":"118664","DOI":"10.1016\/j.bbamcr.2020.118664","volume":"2020","author":"E Lauretti","year":"1867","unstructured":"Lauretti E, Dincer O, Pratic\u00f2 D. Glycogen synthase kinase-3 signaling in Alzheimer's disease. Biochim Biophys Acta Mol Cell Res. 1867;2020(5):118664.","journal-title":"Biochim Biophys Acta Mol Cell Res."},{"key":"935_CR39","first-page":"46","volume":"7","author":"M Llorens-Mart\u00edn","year":"2014","unstructured":"Llorens-Mart\u00edn M, Jurado J, Hern\u00e1ndez F, Avila J. GSK-3\u03b2, a pivotal kinase in Alzheimer disease. Front Mol Neurosci. 2014;7:46.","journal-title":"Front Mol Neurosci."},{"issue":"1","key":"935_CR40","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/0304-3940(92)90774-2","volume":"147","author":"DP Hanger","year":"1992","unstructured":"Hanger DP, Hughes K, Woodgett JR, Brion JP, Anderton BH. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci Lett. 1992;147(1):58\u201362.","journal-title":"Neurosci Lett."},{"issue":"14","key":"935_CR41","doi-asserted-by":"publisher","first-page":"9359","DOI":"10.1074\/jbc.M707108200","volume":"283","author":"MH Magdesian","year":"2008","unstructured":"Magdesian MH, Carvalho MM, Mendes FA, Saraiva LM, Juliano MA, Juliano L, et al. Amyloid-beta binds to the extracellular cysteine-rich domain of Frizzled and inhibits Wnt\/beta-catenin signaling. J Biol Chem. 2008;283(14):9359\u201368.","journal-title":"J Biol Chem."},{"issue":"5","key":"935_CR42","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.neuint.2012.07.003","volume":"61","author":"HF Green","year":"2012","unstructured":"Green HF, Nolan YM. GSK-3 mediates the release of IL-1\u03b2, TNF-\u03b1 and IL-10 from cortical glia. Neurochem Int. 2012;61(5):666\u201371.","journal-title":"Neurochem Int."},{"issue":"4","key":"935_CR43","doi-asserted-by":"publisher","first-page":"M200","DOI":"10.1093\/gerona\/55.4.M200","volume":"55","author":"HJ McCarty","year":"2000","unstructured":"McCarty HJ, Roth DL, Goode KT, et al. Longitudinal course of behavioral problems during Alzheimer's disease: linear versus curvilinear patterns of decline. J Gerontol A Biol Sci Med Sci. 2000;55(4):M200\u20136.","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"935_CR44","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.2147\/DDDT.S173970","volume":"12","author":"SK Rad","year":"2018","unstructured":"Rad SK, Arya A, Karimian H, et al. Mechanism involved in insulin resistance via accumulation of \u03b2-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer's disease. Drug Des Devel Ther. 2018;12:3999\u20134021.","journal-title":"Drug Des Devel Ther."},{"issue":"1","key":"935_CR45","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/bpa.12902","volume":"31","author":"DT Ohm","year":"2021","unstructured":"Ohm DT, Fought AJ, Martersteck A, et al. Accumulation of neurofibrillary tangles and activated microglia is associated with lower neuron densities in the aphasic variant of Alzheimer's disease. Brain Pathol. 2021;31(1):189\u2013204.","journal-title":"Brain Pathol."},{"issue":"6","key":"935_CR46","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/alz.12089","volume":"16","author":"S Muraoka","year":"2020","unstructured":"Muraoka S, DeLeo AM, Sethi MK, Yukawa-Takamatsu K, Yang Z, Ko J, et al. Proteomic and biological profiling of extracellular vesicles from Alzheimer's disease human brain tissues. Alzheimers Dement. 2020;16(6):896\u2013907.","journal-title":"Alzheimers Dement."},{"issue":"1","key":"935_CR47","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer's disease. Mol Neurodegener. 2019;14(1):32.","journal-title":"Mol Neurodegener."},{"issue":"2","key":"935_CR48","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1083\/jcb.201806205","volume":"218","author":"L Liu","year":"2019","unstructured":"Liu L, Ding L, Rovere M, Wolfe MS, Selkoe DJ. A cellular complex of BACE1 and \u03b3-secretase sequentially generates A\u03b2 from its full-length precursor. J Cell Biol. 2019;218(2):644\u201363.","journal-title":"J Cell Biol."},{"key":"935_CR49","doi-asserted-by":"crossref","unstructured":"Hampel H, Vassar R, De Strooper B, et al. The \u03b2-Secretase BACE1 in Alzheimer's Disease. Biol Psychiatry. 2021;89(8):745\u201356.","DOI":"10.1016\/j.biopsych.2020.02.001"},{"issue":"14","key":"935_CR50","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1073\/pnas.1017033108","volume":"108","author":"M Jin","year":"2011","unstructured":"Jin M, Shepardson N, Yang T, Chen G, Walsh D, Selkoe DJ. Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc Natl Acad Sci U S A. 2011;108(14):5819\u201324.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"935_CR51","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1471-4159.2010.06608.x","volume":"113","author":"R Kimura","year":"2010","unstructured":"Kimura R, Devi L, Ohno M. Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice. J Neurochem. 2010;113(1):248\u201361.","journal-title":"J Neurochem."},{"issue":"1","key":"935_CR52","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1124\/jpet.109.163691","volume":"333","author":"M Townsend","year":"2010","unstructured":"Townsend M, Qu Y, Gray A, et al. Oral treatment with a gamma-secretase inhibitor improves long-term potentiation in a mouse model of Alzheimer's disease. J Pharmacol Exp Ther. 2010;333(1):110\u20139.","journal-title":"J Pharmacol Exp Ther."},{"issue":"7","key":"935_CR53","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1194\/jlr.R075796","volume":"58","author":"M Shinohara","year":"2017","unstructured":"Shinohara M, Tachibana M, Kanekiyo T, Bu G. Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies. J Lipid Res. 2017;58(7):1267\u201381.","journal-title":"J Lipid Res."},{"issue":"15","key":"935_CR54","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1523\/JNEUROSCI.3442-16.2017","volume":"37","author":"CC Liu","year":"2017","unstructured":"Liu CC, Hu J, Zhao N, Wang J, Wang N, Cirrito JR, et al. Astrocytic LRP1 Mediates Brain A\u03b2 Clearance and Impacts Amyloid Deposition. J Neurosci. 2017;37(15):4023\u201331.","journal-title":"J Neurosci."},{"issue":"1","key":"935_CR55","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13024-018-0286-0","volume":"13","author":"Q Ma","year":"2018","unstructured":"Ma Q, Zhao Z, Sagare AP, Wu Y, Wang M, Owens NC, et al. Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-\u03b242 by LRP1-dependent apolipoprotein E isoform-specific mechanism. Mol Neurodegener. 2018;13(1):57.","journal-title":"Mol Neurodegener."},{"issue":"1","key":"935_CR56","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1172\/JCI81108","volume":"126","author":"SE Storck","year":"2016","unstructured":"Storck SE, Meister S, Nahrath J, Mei\u00dfner JN, Schubert N, Di Spiezio A, et al. Endothelial LRP1 transports amyloid-\u03b2(1-42) across the blood-brain barrier. J Clin Invest. 2016;126(1):123\u201336.","journal-title":"J Clin Invest."},{"issue":"1-2","key":"935_CR57","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.brainres.2004.05.029","volume":"1017","author":"DR Howlett","year":"2004","unstructured":"Howlett DR, Richardson JC, Austin A, et al. Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes. Brain Res. 2004;1017(1-2):130\u20136.","journal-title":"Brain Res."},{"issue":"6","key":"935_CR58","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/ana.20101","volume":"55","author":"F Trinchese","year":"2004","unstructured":"Trinchese F, Liu S, Battaglia F, Walter S, Mathews PM, Arancio O. Progressive age-related development of Alzheimer-like pathology in APP\/PS1 mice. Ann Neurol. 2004;55(6):801\u201314.","journal-title":"Ann Neurol."},{"issue":"1","key":"935_CR59","doi-asserted-by":"publisher","first-page":"203.e1","DOI":"10.1016\/j.neurobiolaging.2010.07.023","volume":"33","author":"S Lagadec","year":"2012","unstructured":"Lagadec S, Rotureau L, H\u00e9mar A, et al. Early temporal short-term memory deficits in double transgenic APP\/PS1 mice. Neurobiol Aging. 2012;33(1):203.e1\u201311.","journal-title":"Neurobiol Aging"},{"key":"935_CR60","doi-asserted-by":"publisher","unstructured":"Fei X, Zhang Y, Mei Y, et al. Degradation of FA reduces A\u03b2 neurotoxicity and Alzheimer-related phenotypes. Mol Psychiatry. 2020. https:\/\/doi.org\/10.1038\/s41380-020-00929-7.","DOI":"10.1038\/s41380-020-00929-7"},{"key":"935_CR61","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.trci.2019.09.007","volume":"5","author":"X Yue","year":"2019","unstructured":"Yue X, Mei Y, Zhang Y, et al. New insight into Alzheimer's disease: Light reverses A\u03b2-obstructed interstitial fluid flow and ameliorates memory decline in APP\/PS1 mice. Alzheimers Dement (N Y). 2019;5:671\u201384.","journal-title":"Alzheimers Dement (N Y)"},{"key":"935_CR62","doi-asserted-by":"publisher","first-page":"117430","DOI":"10.1016\/j.lfs.2020.117430","volume":"246","author":"Z Peng","year":"2020","unstructured":"Peng Z, Luo Y, Xiao ZY. Angiopoietin-1 accelerates Alzheimer's disease via FOXA2\/PEN2\/APP pathway in APP\/PS1 mice. Life Sci. 2020;246:117430.","journal-title":"Life Sci."},{"issue":"4","key":"935_CR63","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/bies.10251","volume":"25","author":"A Al-Chalabi","year":"2003","unstructured":"Al-Chalabi A, Miller CC. Neurofilaments and neurological disease. Bioessays. 2003;25(4):346\u201355.","journal-title":"Bioessays."},{"issue":"1","key":"935_CR64","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/ana.24052","volume":"75","author":"CS Scherling","year":"2014","unstructured":"Scherling CS, Hall T, Berisha F, et al. Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration. Ann Neurol. 2014;75(1):116\u201326.","journal-title":"Ann Neurol."},{"issue":"2","key":"935_CR65","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","volume":"25","author":"O Preische","year":"2019","unstructured":"Preische O, Schultz SA, Apel A, et al. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease. Nat Med. 2019;25(2):277\u201383.","journal-title":"Nat Med."},{"issue":"1","key":"935_CR66","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neuron.2016.05.018","volume":"91","author":"M Bacioglu","year":"2016","unstructured":"Bacioglu M, Maia LF, Preische O, et al. Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases. Neuron. 2016;91(1):56\u201366.","journal-title":"Neuron."},{"issue":"8","key":"935_CR67","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/acn3.325","volume":"3","author":"LH Meeter","year":"2016","unstructured":"Meeter LH, Dopper EG, Jiskoot LC, et al. Neurofilament light chain: a biomarker for genetic frontotemporal dementia. Ann Clin Transl Neurol. 2016;3(8):623\u201336.","journal-title":"Ann Clin Transl Neurol."},{"issue":"13","key":"935_CR68","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1212\/WNL.0000000000003154","volume":"87","author":"JD Rohrer","year":"2016","unstructured":"Rohrer JD, Woollacott IO, Dick KM, et al. Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia. Neurology. 2016;87(13):1329\u201336.","journal-title":"Neurology."},{"issue":"7","key":"935_CR69","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","volume":"76","author":"N Mattsson","year":"2019","unstructured":"Mattsson N, Cullen NC, Andreasson U, Zetterberg H, Blennow K. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease. JAMA Neurol. 2019;76(7):791\u20139.","journal-title":"JAMA Neurol."},{"issue":"4","key":"935_CR70","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.niox.2010.08.005","volume":"23","author":"AV Goryacheva","year":"2010","unstructured":"Goryacheva AV, Kruglov SV, Pshennikova MG, et al. Adaptation to intermittent hypoxia restricts nitric oxide overproduction and prevents beta-amyloid toxicity in rat brain. Nitric Oxide. 2010;23(4):289\u201399.","journal-title":"Nitric Oxide."},{"issue":"2","key":"935_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1513","volume":"10","author":"SX Meng","year":"2020","unstructured":"Meng SX, Wang B, Li WT. Intermittent hypoxia improves cognition and reduces anxiety-related behavior in APP\/PS1 mice. Brain Behav. 2020;10(2):e01513.","journal-title":"Brain Behav."},{"issue":"9","key":"935_CR72","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1097\/00005072-199709000-00002","volume":"56","author":"MC Irizarry","year":"1997","unstructured":"Irizarry MC, McNamara M, Fedorchak K, Hsiao K, Hyman BT. APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol. 1997;56(9):965\u201373.","journal-title":"J Neuropathol Exp Neurol."},{"key":"935_CR73","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"JW Kinney","year":"2018","unstructured":"Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer's disease. Alzheimers Dement (N Y). 2018;4:575\u201390.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"4","key":"935_CR74","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, et al. Neuroinflammation in Alzheimer's disease. Lancet Neurol. 2015;14(4):388\u2013405.","journal-title":"Lancet Neurol."},{"issue":"8696","key":"935_CR75","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/0140-6736(90)91101-F","volume":"335","author":"PL McGeer","year":"1990","unstructured":"McGeer PL, McGeer E, Rogers J, Sibley J. Anti-inflammatory drugs and Alzheimer disease. Lancet. 1990;335(8696):1037.","journal-title":"Lancet."},{"issue":"5","key":"935_CR76","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3233\/JAD-2002-4510","volume":"4","author":"GM Pasinetti","year":"2002","unstructured":"Pasinetti GM. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia. J Alzheimers Dis. 2002;4(5):435\u201345.","journal-title":"J Alzheimers Dis."},{"issue":"7407","key":"935_CR77","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1136\/bmj.327.7407.128","volume":"327","author":"M Etminan","year":"2003","unstructured":"Etminan M, Gill S, Samii A. Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies. BMJ. 2003;327(7407):128.","journal-title":"BMJ."},{"issue":"7411","key":"935_CR78","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/bmj.327.7411.353","volume":"327","author":"C Martyn","year":"2003","unstructured":"Martyn C. Anti-inflammatory drugs and Alzheimer's disease. BMJ. 2003;327(7411):353\u20134.","journal-title":"BMJ."},{"issue":"3","key":"935_CR79","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3233\/JAD-170706","volume":"62","author":"PL McGeer","year":"2018","unstructured":"McGeer PL, Guo JP, Lee M, Kennedy K, McGeer EG. Alzheimer's Disease Can Be Spared by Nonsteroidal Anti-Inflammatory Drugs. J Alzheimers Dis. 2018;62(3):1219\u201322.","journal-title":"J Alzheimers Dis."},{"issue":"9","key":"935_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222505","volume":"14","author":"J Benito-Le\u00f3n","year":"2019","unstructured":"Benito-Le\u00f3n J, Contador I, Vega S, Villarejo-Galende A, Bermejo-Pareja F. Non-steroidal anti-inflammatory drugs use in older adults decreases risk of Alzheimer's disease mortality. PLoS One. 2019;14(9):e0222505.","journal-title":"PLoS One."},{"issue":"20","key":"935_CR81","doi-asserted-by":"publisher","first-page":"7504","DOI":"10.1523\/JNEUROSCI.23-20-07504.2003","volume":"23","author":"Q Yan","year":"2003","unstructured":"Yan Q, Zhang J, Liu H, et al. Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease. J Neurosci. 2003;23(20):7504\u20139.","journal-title":"J Neurosci."},{"issue":"4","key":"935_CR82","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/cns.12677","volume":"23","author":"S Zhu","year":"2017","unstructured":"Zhu S, Wang J, Zhang Y, et al. The role of neuroinflammation and amyloid in cognitive impairment in an APP\/PS1 transgenic mouse model of Alzheimer's disease. CNS Neurosci Ther. 2017;23(4):310\u201320.","journal-title":"CNS Neurosci Ther."},{"issue":"6","key":"935_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039035","volume":"7","author":"Y Zheng","year":"2012","unstructured":"Zheng Y, Wang Q, Xiao B, Lu Q, Wang Y, Wang X. Involvement of receptor tyrosine kinase Tyro3 in amyloidogenic APP processing and \u03b2-amyloid deposition in Alzheimer's disease models. PLoS One. 2012;7(6):e39035.","journal-title":"PLoS One."},{"issue":"1","key":"935_CR84","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1742-2094-2-9","volume":"2","author":"NS Patel","year":"2005","unstructured":"Patel NS, Paris D, Mathura V, Quadros AN, Crawford FC, Mullan MJ. Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease. J Neuroinflammation. 2005;2(1):9.","journal-title":"J Neuroinflammation."},{"key":"935_CR85","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3389\/fcell.2018.00132","volume":"6","author":"R Chen","year":"2018","unstructured":"Chen R, Lai UH, Zhu L, Singh A, Ahmed M, Forsyth NR. Reactive Oxygen Species Formation in the Brain at Different Oxygen Levels: The Role of Hypoxia Inducible Factors. Front Cell Dev Biol. 2018;6:132.","journal-title":"Front Cell Dev Biol."},{"issue":"2","key":"935_CR86","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4103\/1673-5374.290898","volume":"16","author":"H Hassan","year":"2021","unstructured":"Hassan H, Chen R. Hypoxia in Alzheimer's disease: effects of hypoxia inducible factors. Neural Regen Res. 2021;16(2):310\u20131.","journal-title":"Neural Regen Res."},{"issue":"12","key":"935_CR87","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1001\/jamapsychiatry.2015.1852","volume":"72","author":"S Thielke","year":"2015","unstructured":"Thielke S, Slatore CG, Banks WA. Association Between Alzheimer Dementia Mortality Rate and Altitude in California Counties. JAMA Psychiatry. 2015;72(12):1253\u20134.","journal-title":"JAMA Psychiatry."},{"key":"935_CR88","doi-asserted-by":"crossref","unstructured":"Serebrovska ZO, Serebrovska TV, Kholin VA, et al. Intermittent Hypoxia-Hyperoxia Training Improves Cognitive Function and Decreases Circulating Biomarkers of Alzheimer's Disease in Patients with Mild Cognitive Impairment: A Pilot Study. Int J Mol Sci. 2019;20(21):5405.","DOI":"10.3390\/ijms20215405"},{"key":"935_CR89","doi-asserted-by":"publisher","first-page":"153331751989672","DOI":"10.1177\/1533317519896725","volume":"35","author":"H Wang","year":"2020","unstructured":"Wang H, Shi X, Schenck H, et al. Intermittent Hypoxia Training for Treating Mild Cognitive Impairment: A Pilot Study. Am J Alzheimers Dis Other Demen. 2020;35:1533317519896725.","journal-title":"Am J Alzheimers Dis Other Demen."},{"issue":"14","key":"935_CR90","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14182","volume":"7","author":"J Suzuki","year":"2019","unstructured":"Suzuki J. Effects of exercise training with short-duration intermittent hypoxia on endurance performance and muscle metabolism in well-trained mice. Physiol Rep. 2019;7(14):e14182.","journal-title":"Physiol Rep."},{"key":"935_CR91","doi-asserted-by":"crossref","unstructured":"Snyder B, Shell B, Cunningham JT, Cunningham RL. Chronic intermittent hypoxia induces oxidative stress and inflammation in brain regions associated with early-stage neurodegeneration. Physiol Rep. 2017;5(9):e13258.","DOI":"10.14814\/phy2.13258"},{"issue":"2","key":"935_CR92","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3233\/JAD-130419","volume":"37","author":"S Shiota","year":"2013","unstructured":"Shiota S, Takekawa H, Matsumoto SE, et al. Chronic intermittent hypoxia\/reoxygenation facilitate amyloid-\u03b2 generation in mice. J Alzheimers Dis. 2013;37(2):325\u201333.","journal-title":"J Alzheimers Dis."},{"issue":"7632","key":"935_CR93","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature20587","volume":"540","author":"HF Iaccarino","year":"2016","unstructured":"Iaccarino HF, Singer AC, Martorell AJ, et al. Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature. 2016;540(7632):230\u20135.","journal-title":"Nature."},{"issue":"2","key":"935_CR94","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.cell.2019.02.014","volume":"177","author":"AJ Martorell","year":"2019","unstructured":"Martorell AJ, Paulson AL, Suk HJ, et al. Multi-sensory Gamma Stimulation Ameliorates Alzheimer's-Associated Pathology and Improves Cognition. Cell. 2019;177(2):256\u2013271.e22.","journal-title":"Cell"},{"key":"935_CR95","doi-asserted-by":"crossref","unstructured":"Hadanny A, Efrati S. The Hyperoxic-Hypoxic Paradox. Biomolecules. 2020;10(6):958.","DOI":"10.3390\/biom10060958"},{"issue":"1-2","key":"935_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2005.04.075","volume":"1055","author":"LL Zhu","year":"2005","unstructured":"Zhu LL, Zhao T, Li HS, et al. Neurogenesis in the adult rat brain after intermittent hypoxia. Brain Res. 2005;1055(1-2):1\u20136.","journal-title":"Brain Res."},{"key":"935_CR97","first-page":"144","volume":"2","author":"US Bhalala","year":"2014","unstructured":"Bhalala US, Koehler RC, Kannan S. Neuroinflammation and neuroimmune dysregulation after acute hypoxic-ischemic injury of developing brain. Front Pediatr. 2014;2:144.","journal-title":"Front Pediatr."},{"issue":"1","key":"935_CR98","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s40478-020-01051-z","volume":"8","author":"SK Halder","year":"2020","unstructured":"Halder SK, Milner R. Mild hypoxia triggers transient blood-brain barrier disruption: a fundamental protective role for microglia. Acta Neuropathol Commun. 2020;8(1):175.","journal-title":"Acta Neuropathol Commun."}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00935-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-021-00935-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00935-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T20:03:53Z","timestamp":1675973033000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-021-00935-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,29]]},"references-count":98,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["935"],"URL":"https:\/\/doi.org\/10.1186\/s13195-021-00935-z","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,29]]},"assertion":[{"value":"2 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"194"}}